People who have had depression are more likely to develop Alzheimer’s disease than people who have never had depression, according to a study published in the April 8, 2008, issue of Neurology, the medical journal of the American Academy of Neurology.
The study involved 486 people age 60 to 90 who had no dementia. Of those, 134 people had experienced at least one episode of depression that prompted them to seek medical advice.
The participants were followed for an average of six years. During that time 33 people developed Alzheimer’s disease. People who had experienced depression were 2.5 times more likely to develop Alzheimer’s disease than people who had never had depression. The risk was even higher for those whose depression occurred before the age of 60; they were nearly four times more likely to develop Alzheimer’s than those with no depression.
“We don’t know yet whether depression contributes to the development of Alzheimer’s disease or whether another unknown factor causes both depression and dementia,” said study author Monique M.B. Breteler, MD, PhD, with the Erasmus University Medical Center in Rotterdam, the Netherlands. “We’ll need to do more studies to understand the relationship between depression and dementia.”
One theory was that depression leads to loss of cells in two areas of the brain, the hippocampus and the amygdala, which then contributes to Alzheimer’s disease. But this study found no difference in the size of these two brain areas between people with depression and people who had never had depression.
The study also assessed whether the participants had symptoms of depression at the start of the study. But those with depressive symptoms at the start of the study were not more likely to develop Alzheimer’s than those with no depression at the start of the study.
Source: American Academy of Neurology
Related stories:
Vitamin B supplementation did not slow cognitive decline in patients with Alzheimer disease
High-dose vitamin B supplementation for patients with mild to moderate Alzheimer disease did not slow the rate of cognitive decline, according to a study in the October 15 issue of
JAMA.
Alzheimer's disease risks are gender specific
The risks of developing Alzheimer’s disease differ between the sexes, with stroke in men, and depression in women, critical factors, suggests research published ahead of print in the
Journal of Neurology Neurosurgery and Psychiatry.
New drug may help rescue the aging brain
As people age, their brains pay the price — inflammation goes up, levels of certain neurotransmitters go down, and the result is a plethora of ailments ranging from memory impairment and depression to Alzheimer’s and Parkinson’s. But in a long-term study with implications to treat these and other conditions, researchers have found that an experimental drug, taken chronically, has the ability to stem the effects of aging in the rat brain.
Families need help coping with so-called mild cognitive impairment, research shows
The age-related memory condition known as mild cognitive impairment is more disruptive of day-to-day life and relationships than once believed, gerontology researchers at Virginia Tech have discovered.
For treating advanced Parkinson's, new research points to serotonin
For most people with Parkinson’s disease, the only relief from the tremors, rigidity and impaired movement associated with the progressive loss of their motor skills is a drug called L-DOPA. But as the disease progresses, L-DOPA can cause prominent side effects that counteract its effectiveness.
Mental and physical exercise delays dementia in fatal genetic disease
Scientists at Melbourne’s Howard Florey Institute have discovered that mental and physical stimulation delays the onset of dementia in the fatal genetic disease, Huntington's disease.
New treatment mechanisms for schizophrenia
The field of schizophrenia research has come alive with many exciting new potential approaches to treatment. From the introduction of chlorpromazine to the current day, all treatments approved by the U.S. Food and Drug Administration have had, at their core, a single treatment mechanism, the blockade of the dopamine D2 receptor.
Why some depressed girls can't smell the roses
Can’t smell the roses? Maybe you’re depressed. Smell too much like a rose yourself? Maybe you’ve got the same problem. Scientists from Tel Aviv University recently linked depression to a biological mechanism that affects the olfactory glands. It might explain why some women, without realizing it, wear too much perfume.